期刊文献+

注射用兰索拉唑在输液中的配伍稳定性及联合用药中的配伍禁忌 被引量:10

Compatibility of lansoprazole for injection with four infusion solutions and incompatibility with other drugs
原文传递
导出
摘要 目的:探讨临床上与注射用兰索拉唑与常用输液的配伍稳定性及其在联合用药中的配伍禁忌,为其在临床中的合理使用提供参考,确保患者的用药安全。方法:通过检索国内数据库,查阅近年来有关注射用兰索拉唑在联合用药中存在的配伍禁忌及其在常用输液中配伍稳定性研究的相关文献,并对结果进行分析及总结。结果:注射用兰索拉唑在0.9%氯化钠注射液中配伍6 h内稳定,其与多种药物联合应用存在配伍禁忌。结论:注射用兰索拉唑在临床使用时应采用0.9%氯化钠注射液配伍,同时应充分认识并掌握丹参注射液的配伍禁忌,减少其不良反应的发生。 Objective: To review the compatibility of lansoprazole for injection with four kinds of infusions and incompatibility with other drugs to provide reference for its safe use in clinic. Methods: The reports on compatibility and incompatibility of lansoprazole for injection in domestic medical journals in recent years were collected and reviewed. Results: Lansoprazole for injection was stable in normal saline solutions for 6h and it has incompatibility with many drugs. Conclusion: The lansoprazole for injection should be dissolved in 0.9% sodium chloride solution. It is important to have good knowledge about the incompatibility of lansoprazole for injection with other drugs to reduce adverse drug events.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第19期2331-2334,共4页 Chinese Journal of New Drugs
关键词 注射用兰索拉唑 配伍稳定性 配伍禁忌 联合用药 lansoprazole for injection compatibility incompatibility combined medication
  • 相关文献

参考文献33

二级参考文献41

共引文献104

同被引文献50

引证文献10

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部